Now, another Indian company will help bring down global cost of immunising millions of the world's most vulnerable children against five deadly and debilitating diseases.
Indian vaccine company Biological E Ltd has slashed the price of its five-in-one vaccine by 30%.
A supply agreement makes the five-in-one shot available to GAVI for just $1.19 per dose, compared to the 2012 weighted average price of $2.17.
Ten years ago, there was only one European supplier for the five-in-one vaccine at a price of $3.56.
Today there are five suppliers, including two in India, and a price that is down to its lowest level yet.
This new, more cost-effective price provides the opportunity for the GAVI Alliance to pay up to $150 million less over the next four years compared with using lowest cost alternative suppliers.
Dr Seth Berkley, CEO of the GAVI Alliance said "This is great news for children in the world's poorest countries and it shows that our innovative public-private partnership model is working well."
Demand for pentavalent vaccine has been growing globally and was recently introduced in India.
Around 70 of the 73 GAVI-eligible countries having already introduced it, and the three remaining countries - Somalia, Indonesia, and South Sudan - approved to do so.
UNICEF managed the tender process for GAVI, which saw agreements made with Biological E, Crucell, GlaxoSmithKline, Serum Institute of India and new pentavalent supplier, LG Life Sciences of the Republic of Korea.
The GAVI Alliance was created in 2000 to accelerate the introduction of new vaccines so that all children, no matter where they live, have the same access to this life-saving technology. National governments, donors and vaccine suppliers must all play their part to ensure infants in the poorest countries are protected.
Mahima Datla, Managing Director of Biological E said "This partnership demonstrates the growing role of developing world manufacturers in the sustainable supply of effective, affordable vaccines. We are proud that our work to provide affordable prices for a variety of countries means life-saving vaccines can reach the most underprivileged children in the world."
Pentavalent vaccines combine the antigens for five infectious diseases in a single shot, namely diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B (Hib).
Pentavalent is already GAVI's most widely used vaccine and by 2020 GAVI support for this vaccine will have helped to avert more than seven million deaths.
India recently became the 117th country to introduce the pentavalent vaccine in its national immunization programme.
Anda sedang membaca artikel tentang
Now, an Indian effort to cut childhood vaccine prices
Dengan url
http://pijitwajah.blogspot.com/2013/04/now-indian-effort-to-cut-childhood.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Now, an Indian effort to cut childhood vaccine prices
namun jangan lupa untuk meletakkan link
Now, an Indian effort to cut childhood vaccine prices
sebagai sumbernya
0 komentar:
Posting Komentar